Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

News

October 20, 2014 – Heart disease and stroke are the leading causes of death and disability among people with Type 2 ...

Home October 20, 2014
Home
News

October 15, 2014 — Novartis Pharmaceuticals Canada Inc. revealed, in the largest heart failure study to date, that its ...

Home October 15, 2014
Home
News

October 14, 2014 — Researchers have discovered a previously unknown cardiac molecule that could provide a key to ...

Home October 14, 2014
Home
News

September 23, 2014 — New analyses and extended follow-up from the BRIGHT study demonstrated that bivalirudin remained ...

Home September 23, 2014
Home
News

September 22, 2014 — According to a new study, patients receiving six months of dual antiplatelet therapy (DAPT) after ...

Home September 22, 2014
Home
Study Blood Thinner Heart Attack Patients
Feature

September 19, 2014 — The largest prospective longitudinal study of acute myocardial infarction (MI) patients offers ...

Home September 19, 2014
Home
Feature

September 19, 2014 — A new study investigating different durations of triple therapy for anticoagulation after drug ...

Home September 19, 2014
Home
News

September 12, 2014 — The first researcher in the world to discover that aspirin prevents a first attack, Charles H ...

Home September 12, 2014
Home
News

September 3, 2014 –In patients who experienced an acute coronary syndrome (ACS) event (such as heart attack or unstable ...

Home September 03, 2014
Home
News
September 2, 2014 – Janssen Research & Development, LLC (Janssen) and its development partner, Bayer HealthCare ...
Home September 02, 2014
Home
News
August 28, 2014 — The American College of Cardiology and the American Heart Association today released a revised ...
Home August 28, 2014
Home
News

August 25, 2014 — New data revealing the reduction in cardiovascular (CV) deaths with Novartis' LCZ696 in patients with ...

Home August 25, 2014
Home
U.S. Department of Justice Close Investigation PLATO Clinical Trial Ticagrelor
Feature

August 20, 2014 — AstraZeneca received confirmation from the United States Department of Justice that it is closing its ...

Home August 20, 2014
Home
News

August 5, 2014 — The launch of several drugs with “extraordinary blockbuster potential” will cause the acute coronary ...

Home August 05, 2014
Home
Clinical Study Heart Vaccine Pharmaceutical
Feature

August 1, 2014 — Researchers at Wayne State University have made a fundamental discovery and, in subsequent ...

Home August 01, 2014
Home
Subscribe Now